Africa commits to WHO access to medicine goals

Access to medicines is at the core of universal health coverage (UHC), one of World Health Organisation's main priorities, and the Sustainable Development Goals (SDGs)...

30 Aug 2018

Africa needs to grow its pharmaceutical market

Africa urgently needs to develop its pharmaceutical sector to reduce its dependence on imported drugs and medical products...

2 Aug 2018

Generation Z will transform African business

The next-generation workforce is set to drive positive change for Africa's enterprises...

3 Jul 2018

New partnership to boost drug discovery for malaria, TB and more in Africa

A new international partnership has committed funding for the discovery of new drugs for diseases endemic to Africa over the next two years...

29 Jun 2018

Africa hosts very few clinical trials. Why this is bad for innovation

Clinical trials are the foundation of any new medicine. They allow scientists to test the efficacy and safety of a drug or therapy...

By Swapan Kumar Patra 5 Jun 2018

Marketing is key in medicines distribution in Africa

The media is a key platform for dissemination of information around medications on the continent in Africa, where virtual spaza shops for drugs proliferate...

By Nomfundo Dlamini 8 Mar 2018

E-health platform MyDawa disrupting Kenya's healthcare industry

The MyDawa solution is beneficial to consumers as they gain the advantage of having increased transparency, convenience and affordability. In addition, it ensures better pharmacovigilance as it tackles the issue of...

26 Jan 2018

Cipla collaborates with American Cancer Society to increase access to cancer treatment in Africa

Cipla has announced a groundbreaking market access agreement with the American Cancer Society, the Clinton Health Access Imitative and the pharmaceutical company, Pfizer...

Issued by Cipla 7 Jul 2017

Packaging in SA is always changing shape

If there is one industry where everything is in flux and companies have to re-jig their shapes and formats all the time, it is SA's packaging manufacturers. Apart from constantly changing industry conditions, not least from encroaching rivals, each firm has specific obstacles to get over.

By Mark Allix 2 Jun 2014

Counterfeit medicine trade targets Africa's poor

YAOUNDE, CAMEROON: From Cameroon to Ivory Coast, Kenya to the Democratic Republic of Congo (DRC), traders in counterfeit drugs do a thriving business with the utmost cynicism and sometimes at the cost of human lives.

24 Aug 2013

Efforts to tackle malnutrition recieve boost

Glenmark, a global integrated pharmaceutical company, will spend Kshs5 million this year on a three-year programme to address malnutrition in Nairobi's Kibera slums.

By David Njaaga 15 Jul 2013

Africa's growth driven by SA

Although Africa made huge strides in increasing human development in the past decade, gains could - with hundreds of millions of people being pushed into extreme poverty - easily be reversed should "significant progress" not be made in halting global warming.

By Schalk Mouton 20 Mar 2013

Asia-Pacific region drives Aspen's revenue growth

SA's biggest drug manufacturer Aspen Pharmacare expects its Asia-Pacific business to generate the biggest share of the company's revenue by the end of the year‚ its chief executive Stephen Saad said at the release of its interim results for the six months to December.

By Tamar Kahn 8 Mar 2013

Global players behind anti-counterfeit law campaign

KAMPALA: The international push behind Kenya's controversial Anti-Counterfeit Act of 2008 dates back as far as October 2006 when the World Customs Organisation held its first intellectual property rights (IPRs) seminar in Kampala, the capital of neighbouring Uganda, focusing on East African governments' enforcement of these rights.

By Wambi Michael, Christi van der Westhuizen 24 May 2010

Show more